Promising clinical trials for multiple myeloma: KarMMa, CARTITUDE and EVOLVE Noopur Raje, MD, Massachusetts General Hospital, Boston, MA, discusses promising clinical trials in cellular therapies for multiple myeloma. The Phase II trial KarMMa (NCT03361748) reproduced the results from the Phase I trial with a global cohort. The study investigated idecabtagene vicleucel (bb2121), a BCMA-targeted CAR […]

Read More